Treatment-emergent hypertension and outcomes in patients with advanced non-small-cell lung cancer receiving chemotherapy with or without the vascular endothelial growth factor receptor inhibitor cediranib: NCIC Clinical Trials Group Study BR24.

Source:http://linkedlifedata.com/resource/pubmed/id/20427348

Download in:

View as

General Info

PMID
20427348